Neurocardiac Imaging Has a Proven Value in Patient Management

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2017 Jun 9

PMID 28593534

Citations 2

Authors

Mark I Travin

Affiliations

Soon will be listed here.

Citing Articles

Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

AlJaroudi W, Hage F J Nucl Cardiol. 2017; 25(1):320-330.

PMID: 29119374 DOI: 10.1007/s12350-017-1120-8.

Clinical utility of cardiac innervation imaging in patients with heart failure.

Bax J J Nucl Cardiol. 2017; 24(5):1594-1597.

PMID: 28699069 DOI: 10.1007/s12350-017-0988-7.

References

Arora R, Ferrick K, Nakata T, Kaplan R, Rozengarten M, Latif F . I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003; 10(2):121-31. DOI: 10.1067/mnc.2003.2. View

Kober L, Thune J, Nielsen J, Haarbo J, Videbaek L, Korup E . Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med. 2016; 375(13):1221-30. DOI: 10.1056/NEJMoa1608029. View

Raffel D, Wieland D . Development of mIBG as a cardiac innervation imaging agent. JACC Cardiovasc Imaging. 2010; 3(1):111-6. DOI: 10.1016/j.jcmg.2009.09.015. View

Narula J, Gerson M, Thomas G, Cerqueira M, Jacobson A . ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study. J Nucl Med. 2015; 56(7):1011-8. DOI: 10.2967/jnumed.115.156406. View

Minardo J, Tuli M, Mock B, Weiner R, Pride H, WELLMAN H . Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation. 1988; 78(4):1008-19. DOI: 10.1161/01.cir.78.4.1008. View

Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S . A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013; 6(7):772-84. DOI: 10.1016/j.jcmg.2013.02.007. View

Douglas P . Achieving the Full "PROMISE" of Imaging Outcomes Research. Circulation. 2016; 134(5):359-61. PMC: 4975531. DOI: 10.1161/CIRCULATIONAHA.116.022876. View

Travin M . Current Clinical Applications and Next Steps for Cardiac Innervation Imaging. Curr Cardiol Rep. 2017; 19(1):1. DOI: 10.1007/s11886-017-0817-2. View

Stanton M, Tuli M, Radtke N, Heger J, Miles W, Mock B . Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol. 1989; 14(6):1519-26. DOI: 10.1016/0735-1097(89)90391-4. View

10.

Travin M . It's not all in the numbers. J Nucl Cardiol. 2015; 23(3):436-41. DOI: 10.1007/s12350-015-0105-8. View

11.

Kline R, Swanson D, Wieland D, Thrall J, Gross M, Pitt B . Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981; 22(2):129-32. View

12.

Jacobson A, Senior R, Cerqueira M, Wong N, Thomas G, Lopez V . Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. DOI: 10.1016/j.jacc.2010.01.014. View

13.

Travin M, Feng D, Taub C . Novel Imaging Approaches for Predicting Arrhythmic Risk. Circ Cardiovasc Imaging. 2015; 8(11):e003019. DOI: 10.1161/CIRCIMAGING.115.003019. View

14.

Sinusas A, Thomas J, Mills G . The future of molecular imaging. JACC Cardiovasc Imaging. 2011; 4(7):799-806. DOI: 10.1016/j.jcmg.2011.05.003. View

15.

Myerburg R . Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med. 2008; 359(21):2245-53. DOI: 10.1056/NEJMra0803409. View

16.

Merlet P, Valette H, Dubois-Rande J, Moyse D, Duboc D, Dove P . Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992; 33(4):471-7. View

17.

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Drazner M . 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128(16):e240-327. DOI: 10.1161/CIR.0b013e31829e8776. View

18.

Ketchum E, Jacobson A, Caldwell J, Senior R, Cerqueira M, Thomas G . Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol. 2012; 19(5):1007-16. DOI: 10.1007/s12350-012-9603-0. View

19.

Fallavollita J, Heavey B, Luisi Jr A, Michalek S, Baldwa S, Mashtare Jr T . Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2013; 63(2):141-9. PMC: 3954563. DOI: 10.1016/j.jacc.2013.07.096. View

20.

Verberne H, Brewster L, Somsen G, van Eck-Smit B . Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008; 29(9):1147-59. DOI: 10.1093/eurheartj/ehn113. View